title: Liver transplantation for primary sclerosing cholangitis in the Nordic countries: outcome after acceptance to the waiting list.
abstract: Primary sclerosing cholangitis (PSC) is a common indication for liver transplantation, but evaluation of patients and timing of liver transplantation remain as major problems. Data from PSC and control patients listed for liver transplantation from 1990 through 2000 in the Nordic countries were recorded prospectively. Outcomes from the waiting list and after transplantation have been recorded for both groups. For PSC patients, regression analyses have been performed to analyze predictors of outcome. A total of 255 PSC and 610 control patients were accepted on the liver transplantation waiting list from 1990 to 2000. In the PSC group, 223 patients (87%) received a first liver allograft, and 32 patients (13%) died without transplantation. The corresponding figures for the control group were 89% and 10%. For PSC patients, the 5- and 10-year survival from the time of acceptance was 68% and 58%, respectively. A higher Model for End-Stage Liver Disease score and a shorter duration of PSC predicted death on the waiting list for PSC patients. PSC is a frequent indication for liver transplantation. In our material, serum bilirubin or Model for End-Stage Liver Disease score and PSC duration are predictors of outcome including survival of the waiting list.
authors.affiliation: Department of Medicine, Rikshospitalet, Oslo, Norway. bjorn.brandsaeter@rikshospitalet.no
authors.forename: Bjørn
authors.initials: B
authors.lastname: Brandsaeter
authors.forename: Ulrika
authors.initials: U
authors.lastname: Broomé
authors.forename: Helena
authors.initials: H
authors.lastname: Isoniemi
authors.forename: Styrbjörn
authors.initials: S
authors.lastname: Friman
authors.forename: Bent
authors.initials: B
authors.lastname: Hansen
authors.forename: Erik
authors.initials: E
authors.lastname: Schrumpf
authors.forename: Antti
authors.initials: A
authors.lastname: Oksanen
authors.forename: Bo-Göran
authors.initials: BG
authors.lastname: Ericzon
authors.forename: Krister
authors.initials: K
authors.lastname: Höckerstedt
authors.forename: Heikki
authors.initials: H
authors.lastname: Mäkisalo
authors.forename: Rolf
authors.initials: R
authors.lastname: Olsson
authors.forename: Michael
authors.initials: M
authors.lastname: Olausson
authors.forename: Preben
authors.initials: P
authors.lastname: Kirkegaard
authors.forename: Kristian
authors.initials: K
authors.lastname: Bjøro
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D002648:Child; D015209:Cholangitis, Sclerosing / Q000401:mortality* / Q000601:surgery*; D005260:Female; D006801:Humans; D016031:Liver Transplantation / Q000401:mortality*; D008297:Male; D008875:Middle Aged; D011237:Predictive Value of Tests; D011446:Prospective Studies; D012307:Risk Factors; D012537:Scandinavian and Nordic Countries / Q000453:epidemiology; D016019:Survival Analysis; D016896:Treatment Outcome; D014850:Waiting Lists